[Chronic lymphocytic leukemia. 2. Therapy]

Dtsch Med Wochenschr. 2001 Jun 8;126(23):690-5. doi: 10.1055/s-2001-14692.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Bone Marrow Transplantation
  • Chlorambucil / adverse effects
  • Chlorambucil / therapeutic use
  • Dose-Response Relationship, Radiation
  • Drug Therapy, Combination
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunization, Passive
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Risk Factors
  • Splenectomy
  • Steroids / adverse effects
  • Steroids / therapeutic use
  • Transplantation, Autologous
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Steroids
  • Chlorambucil
  • Vidarabine
  • fludarabine